LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
Agreement signedPublished 9 Aug 2022

Eagle Pharmaceuticals, Inc. /
Enalare Therapeutics Inc.

Eagle Pharmaceuticals secures an option to acquire Enalare Therapeutics

Price
$12.5m
Stage
Agreement signed
Source · 9 Aug 2022
See the source
01 / BuyerEagle Pharmaceuticals, Inc.
02 / TargetEnalare Therapeutics Inc.
01

What happened

Eagle Pharmaceuticals, Inc. made an initial $12.5 million equity investment in Enalare Therapeutics Inc. and received an option to acquire the remaining shares it does not already own.

The option provides for a potential acquisition for approximately $100 million to $175 million in the aggregate, plus additional amounts. Terms weren't disclosed.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Eagle Pharmaceuticals secures an option to acquire Enalare Therapeutics

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.